For example, the reduction of IL-10 concentration in TME achieved by intratumoral injections of lentiviral vectors carrying the shRNA sequence directed against IL-10 significantly improved the effectiveness of DC-based vaccines and contributed to the inhibition of the MC38 tumor growth (24). This evidence concerns the gene IL10 and neoplasm.